Research Overview of Arimidyn 0.5mg
Arimidyn 0.5mg by Driada Medical is a pharmaceutical-grade aromatase inhibitor specifically formulated for advanced laboratory research investigating estrogen modulation pathways. This research compound contains anastrozole as its active pharmaceutical ingredient, designed for comprehensive in-vitro studies examining hormonal regulatory mechanisms. Researchers at Stroid UK Shop utilise this compound to investigate aromatase enzyme inhibition in controlled laboratory settings. The formulation represents cutting-edge pharmaceutical manufacturing standards, enabling precise research applications across multiple investigative protocols.
Laboratory Research Applications
Research scientists examine Arimidyn for its potential in studying estrogen synthesis inhibition mechanisms within laboratory frameworks. This compound enables researchers to investigate aromatase enzyme activity modulation, providing valuable insights into hormonal regulation pathways. Studies focus on examining the compound’s interaction with cytochrome P450 enzyme systems, particularly CYP19A1 aromatase. Research applications extend to investigating cellular response mechanisms and examining potential therapeutic pathways. Scientists studying anastrozol estrogen blockers frequently incorporate this compound into comprehensive research protocols. Additional research areas include examining metabolic pathway interactions and investigating cellular signalling cascades related to estrogen production inhibition. Laboratory studies also evaluate the compound’s stability characteristics and examine its potential applications alongside other research compounds such as SARMs and peptides in multi-compound research protocols.
Technical Specifications
| Parameter | Specification |
|---|---|
| Active Compound | Anastrozole |
| Concentration | 0.5mg per tablet |
| Manufacturer | Driada Medical |
| Form | Oral tablets |
| Purity | Pharmaceutical grade |
| CAS Number | 120511-73-1 |
| Molecular Formula | C17H19N5 |
| Storage | Cool, dry conditions |
Research Compliance Statement
Arimidyn 0.5mg Driada Medical is manufactured exclusively for in-vitro research purposes and is not intended for human consumption, therapeutic use, or any application outside controlled laboratory environments. Researchers must ensure compliance with applicable regulations and maintain appropriate laboratory safety protocols when handling this research compound.
